tiprankstipranks
Advertisement

NEWZ - ETF AI Analysis

Compare

Top Page

NEWZ

StockSnips AI-Powered Sentiment US All Cap ETF (NEWZ)

Rating:73Outperform
Price Target:
NEWZ, the StockSnips AI-Powered Sentiment US All Cap ETF, earns a solid overall rating driven largely by strong, growing companies like Alphabet (GOOG) and Catalyst Pharma (CPRX), which benefit from robust financial performance, positive earnings calls, and clear growth initiatives. Additional support comes from holdings such as Krystal Biotech (KRYS) and BWX Technologies (BWXT), though some positions like Ryman (RHP) and Motorola Solutions (MSI) face issues such as high leverage, weaker cash flow trends, or bearish technical signals. The main risk factor is that several holdings show cautionary technical indicators or elevated valuations, which could add volatility even as their long-term stories remain positive.
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any single industry struggles.
Generally Strong Top Holdings
Most of the largest positions have shown strong or steady performance so far this year, supporting the ETF’s recent gains.
Positive Recent Performance
The ETF has delivered solid gains over the past month, three months, and year to date, indicating favorable recent momentum.
Negative Factors
High Expense Ratio
The fund’s management fee is relatively high for an ETF, which can eat into long-term returns for investors.
Concentrated in U.S. Stocks
With almost all assets in U.S. companies, the ETF offers little geographic diversification and is heavily tied to the U.S. market.
Mixed Performance Among Top Holdings
A few of the largest positions have shown weak or negative performance this year, which could drag on the fund if that continues.

NEWZ vs. SPDR S&P 500 ETF (SPY)

NEWZ Summary

The StockSnips AI-Powered Sentiment US All Cap ETF (NEWZ) is a U.S. stock fund that uses artificial intelligence to read news and gauge market mood, instead of tracking a traditional index. It invests across the whole U.S. market—large, mid, and small companies—in many sectors like technology, health care, and energy. Well-known names in its holdings include Cadence Design and SM Energy. Someone might invest for broad diversification and the potential edge of AI-driven stock selection. A key risk is that the AI sentiment strategy can be wrong, and the ETF’s value can go up and down with the stock market.
How much will it cost me?The StockSnips AI-Powered Sentiment US All Cap ETF (Ticker: NEWZ) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed and uses advanced AI technology to analyze market sentiment, which requires more resources and expertise.
What would affect this ETF?The NEWZ ETF, with its focus on U.S. equities and heavy exposure to technology and healthcare sectors, could benefit from advancements in AI, innovation in tech, and increased demand for healthcare services. However, it may face challenges from rising interest rates, regulatory changes affecting AI or healthcare, and economic slowdowns that impact consumer spending and industrial growth.

NEWZ Top 10 Holdings

NEWZ may be marketed as a broad U.S. fund, but its story right now is driven by a handful of sentiment-favored names. MYR Group and SM Energy are doing the heavy lifting, with both stocks rising strongly this year and giving the portfolio a boost from industrial and energy pockets of the market. Lantheus and Cadence Design are also pulling their weight, though Cadence looks a bit stretched after its run. On the softer side, Futu and Maplebear have been more mixed, occasionally dragging on performance despite upbeat fundamentals.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Lantheus4.60%$867.05K$6.06B13.85%
73
Outperform
Catalyst Pharma3.93%$741.54K$3.81B33.29%
83
Outperform
SM Energy3.80%$717.05K$7.06B27.12%
72
Outperform
Ryman3.76%$709.23K$6.98B13.84%
66
Neutral
Krystal Biotech3.71%$700.51K$9.01B131.28%
80
Outperform
Alphabet Class C3.69%$696.12K$4.84T157.19%
82
Outperform
Solventum Corporation3.52%$663.12K$12.71B4.48%
73
Outperform
Eli Lilly & Co3.49%$658.10K$893.19B29.12%
72
Outperform
FirstCash3.39%$639.14K$9.98B71.51%
74
Outperform
Bj's Wholesale Club Holdings3.35%$632.29K$12.06B-18.90%
71
Outperform

NEWZ Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
28.24
Positive
100DMA
27.96
Positive
200DMA
28.01
Positive
Market Momentum
MACD
0.23
Positive
RSI
58.84
Neutral
STOCH
36.82
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NEWZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.92, equal to the 50-day MA of 28.24, and equal to the 200-day MA of 28.01, indicating a bullish trend. The MACD of 0.23 indicates Positive momentum. The RSI at 58.84 is Neutral, neither overbought nor oversold. The STOCH value of 36.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NEWZ.

NEWZ Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$18.86M0.75%
73
Outperform
$98.68M0.65%
71
Outperform
$96.51M0.89%
71
Outperform
$92.92M0.75%
69
Neutral
$92.49M0.85%
74
Outperform
$84.10M0.52%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NEWZ
StockSnips AI-Powered Sentiment US All Cap ETF
29.01
1.45
5.26%
YALL
God Bless America ETF
BAMD
Brookstone Dividend Stock ETF
SOVF
Sovereign's Capital Flourish Fund
STNC
Stance Equity ESG Large Cap Core ETF
RFDA
RiverFront Dynamic US Dividend Advantage ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement